Professional Documents
Culture Documents
IJPS - Volume 3 - Issue 1 - Pages 51-56
IJPS - Volume 3 - Issue 1 - Pages 51-56
Original Article
aDepartment
of Medicinal Chemistry,
bDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, and Pharmaceutical
Sciences Research Center, University of Tehran/ Medical Sciences, Tehran, Iran
Abstract
Licorice is obtained from Glycyrrhiza glabra (G. glabra) in Iran. Glycyrrhizin
is the main constituent of G. glabra and has several pharmacological effects. It is
hydrolyzed to glycyrrhetic acid (GA) in the intestine after oral administration. In
this study, a novel HPLC method was used to determine the concentration of GA
in rat plasma after oral administration of licorice aqueous extract. The method was
linear (r2 >0.999) in the range of 0.1-5.0 μg/ml for GA. Maximum plasma
concentration of GA was achieved 8 h after oral administration of licorice aqueous
extract. The developed method was suitable for determination of GA in rat plasma.
Table 1. Precision and accuracy of the developed HPLC method for determining glycyrrhetic acid in spiked rat plasma (n=9,
three sets for 3 days).
Concentration Concentration found CV Error Accuracy
added (μg.ml-1) (mean ± SD)(μg.ml-1) (%) (%) (%)
Within-day (n=3)
0.1 0.090±0.030 3.33 -10.00 90.0
1.0 1.010±0.043 4.26 1.00 99.0
5.0 4.990±0.036 0.72 -0.20 99.8
Between-days (n=9)
0.1 0.088±0.000 4.55 -13.00 87.0
1.0 1.010±0.042 4.16 1.00 99.0
5.0 5.000±0.065 1.30 0.00 100.0
52
Detection of glycerrhetic acid in rat serum
2.7. Validation
Six series of standard calibration solutions
were prepared in the blank plasma in the
range of 0.1-5.0 μg/ml. The sample
preparation and HPLC analysis were
performed as described above. Calibration
curves were constructed by plotting the
measured peak area ratios of GA to internal
standard versus concentrations of standard
samples and the statistical analysis was
performed. To establish the accuracy and
precision of the method, three replicates of the
standard plasma solutions at three different
concentrations (0.1, 1 and 5 μg/ml) were
assayed on one day and three separate days.
Within-day and between-days variations were
calculated.
53
F Shamsa / IJPS Winter 2007; 3(1): 51-56
of blood samples were required, seven rats h). These facts could be explained on the
were used for blood collecting at each time basis of the antimicrobial effects of GL [3, 6,
point. Samples were immediately centrifuged 7] which might cause less available GA for
at 4500 rpm for 10 min. to separate the absorption.
plasma. Under the chromatographic conditions
described in the present procedure, GA and
3. Results and discussion internal standard were well resolved from
For the past 30 years, GL (the active licorice extract or plasma samples with no
ingredient of G. glabra) has found its way to interfering peaks (Figure 1). The calibration
the modern therapeutic applications. This is curve of GA was linear in the range of 0.1-5.0
due to the fact that this compound is available μg/ml plasma with LOD of 0.02 μg/ml and
in significant amounts in licorice (>3%) in typical equation of Y=(0.732±0.002)X-
addition to its various pharmacological effects 0.019±0.005 and r2 > 0.999. The linearity is
[1-6]. Therefore, many researchers have validated by the high value of the correlation
developed various analytical methods for coefficient. The accuracy and precision of
determination of GL in biological samples the method for analyzing GA in plasma were
[9-14]. As G. glabra is naturally grown in determined by assaying three samples at 0.1,
Iran in different regions and exported in large 1.0, and 5.0 μg/ml on three separate days.
amounts annually, it was decided to optimize Concentrations were determined using
an HPLC condition for analysis of GA in calibration standard curve prepared in the
plasma after consumption of licorice aqueous range of 0.1-5.0 μg/ml. Good accuracy and
extract. It is interesting to find that the Cmax precision were observed over the entire
of GA is higher for Iranian licorice (2.12±0.33 concentration range (Table 1). The within-day
vs. 1.64±0.77 mg/ml for pure GL), although and between-day variability showed CV
GL was administered orally at 100 mg/kg to values less then 4.5% in all three selected
rats (Table 2) [13]. In addition, Tmax is shorter concentrations.
for Iranian licorice than pure GL (8.0 vs. 11.2 The limit of quantification with CV<4.5%
Figure 2. Mean plasma concentration-time curve of glycyrrhetic acid following oral administration of licorice decoction to
7 rats.
54
Detection of glycerrhetic acid in rat serum
Table 2. Glycyrrhetic acid concentration in rat plasma at different periods of time after oral administration of licorice aqueous
extract.
GA concentration (μg/ml) at time (h)
Rat 2 4 6 8 10 12 14
1 0.18 1.12 1.69 2.31 1.93 0.80 0.21
2 0.40 0.75 1.62 2.25 1.29 1.08 0.53
3 0.55 0.89 1.75 1.76 2.27 1.00 0.66
4 0.38 1.05 1.43 1.83 1.73 1.37 0.71
5 0.22 0.53 1.11 2.65 0.98 0.66 0.49
6 0.23 1.15 1.58 2.47 1.98 0.89 0.44
7 0.67 1.28 1.46 2.16 2.50 0.78 0.60
Mean 0.38 0.967 1.52 2.12 1.89 0.94 0.49
SD 0.23 0.48 0.72 0.33 0.56 0.41 0.24
CV% 60.50 ND 49.60 47.40 15.56 29.63 ND
ND: Not detected
was found to be 0.1 μg/ml for GA. The limit S, Nomura T. Anti-Helicobacter pylori flavonoids
of detection that can be reliably detected with from licorice extract. Life Sci 2002; 71: 1449-63.
[7] Hattori M, Sakamoto T, Yamagishi T. Metabolism
S/N ratio of 3 was found to be 0.02 μg/ml. The of glycyrrhizin by human intestinal flora. II.
method was successfully used for Isolation and characterization of human intestinal
determination of GA in rat plasma. The bacteria capable of metabolizing glycyrrhizin
plasma concentration of GA, the main and related compounds. Chem Pharm Bull 1985;
metabolite of glycyrrhizin after oral 33: 210-7.
[8] Bernardi M, D'Intino PE, Trevisani F, Cantelli-
administration of licorice extract to rats is forti G, Raggi MA, Turchetto E, Gasbarrini G.
presented in Table 2 and Figure 2. From the Effects of prolonged ingestion of graded doses of
results of this study it might be concluded that licorice by healthy volunteers. Life Sci 1994; 55:
this simple and reliable method could be used 863-72.
for determining GA in human plasma for [9] Brown-Thomas JM, Christensen RG, Rieger R,
Malone W, May WE. Determination of
pharmacokinetic and therapeutic drug glycyrrhetinic acid in human plasma by high
monitoring studies. performance liquid chromatography. J
Chromatogr 1991; 568: 232-8.
References [10] Tsai TH, Chen CF. High-performance liquid chro-
[1] Morgan AG, McAdam WA. Glycyrrhiza glabra matographic determination of 18 α-glycyrrhetinic
monograph. Altern Med Rev 2005; 10: 230-7. acid and 18β-glycyrrhetinic acid in rat plasma:
[2] Dhingra D, Parle M, Kulkarni SK. Memory application to pharmacokinetic study. J
enhancing activity of Glycyrrhiza glabra in mice. Chromatogr B 1991; 567: 405-14.
J Ethnopharmacol 2004; 41: 361-5. [11] Russel FGM, van Uum S, Tan Y, Smits P. Solid-
[3] Ceremelli C, Portolani M, Cotombari B, Castelli phase extraction of 18β-glycyrrhetinic acid from
M, Baggio G, Galatulas I. Activity of glycyrrhizin plasma and subsequent analysis by high-
and its diasterioisomers against two new human performance liquid chromatography. J
herpes virus: HHV-6 and HHV-7. Phytochem Chromatogr B 1998; 710: 223-6.
Res 1996; 10: 527-8. [12] Takeda S, Ishihara K, Wakui Y, Amagaya S,
[4] Akamatsu H, Komura J, Asada Y, Niwa Y. Maruno M, Akao T, Kobashi K. Bioavailability
Mechanism of anti-inflammatory action of study of glycyrrhetic acid after oral administration
glycyrrhizin: Effect on neutrophil functions of glycyrrhizin in rats; relevance to the intestinal
including reactive oxygen species generation. bacterial hydrolysis. J Pharm Pharmacol 1996;
Planta Med 1991; 57: 119-21. 48: 902-5.
[5] Nagai T, Egashira T, Kudo Y, Yamanaka Y, [13] Gao QT, Chen XH, Bi SK. Comparative pharma-
Shimada T. Attenuation of dysfunction in the cokinetic behavior of glycyrrhetic acid after oral
ischemia-reperfused liver by glycyrrhizin. Japn administration of glycyrrhizic acid and Gancao-
J Pharmacol 1992; 58: 209-18. Fuzi-Tang. Biol Pharm Bull 2004; 27: 226-8.
[6] Fukai T, Marumo A, Kaitou K, Kanda T, Terada [14] Lin SJ, Tseng HH, Wen KC, Suen TT.
55
F Shamsa / IJPS Winter 2007; 3(1): 51-56
56